Home | Business News | Browse by Publication | B | Biotech Business

PROFECTUS BIOSCIENCES/MVI TO CONDUCT PROOF-OF-CONCEPT STUDY.

Publication: Biotech Business
Publication Date: 01-OCT-09
Format: Online
Delivery: Immediate Online Access

Article Excerpt
Profectus BioSciences, Inc. (Profectus), a clinical stage biopharmaceutical company focused on the development of novel vaccine candidates for serious chronic infections, has entered into a research collaboration agreement with the PATH Malaria Vaccine Initiative (MVI) to conduct proof-of-concept study with its proprietary, recombinant vesicular stomatitis virus (rVSV) vector technology as a preventative malaria vaccine.

Shawn Patrick O'Brien, President and Chief Executive Officer of Profectus BioSciences, commented, "We...

Access Full Article, Compliments of Goliath

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Biotech Business
STEMEDICA REQUESTS PRE-IND MEETING WITH FDA., October 01, 2009
FDA ACCEPTS SALIX NDA FOR PRIORITY REVIEW., October 01, 2009
ENDOCYTE GETS MILESTONE PAYMENT FROM BRISTOL-METERS SQUIBB., October 01, 2009
HAWAII BIOTECH BEGINS PHASE 1 CLINICAL TRIAL FOR DENGUE VACCINE., October 01, 2009

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.